Currently, there are 577.00M common shares owned by the public and among those 557.37M shares have been available to trade.
The company’s stock has a 5-day price change of 0.22% and -3.29% over the past three months. MRO shares are trading 14.40% year to date (YTD), with the 12-month market performance up to 3.33% higher. It has a 12-month low price of $21.81 and touched a high of $30.06 over the same period. MRO has an average intraday trading volume of 5.78 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.74%, 0.81%, and 4.62% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Marathon Oil Corporation (NYSE: MRO) shares accounts for 76.35% of the company’s 577.00M shares outstanding.
It has a market capitalization of $15.46B and a beta (3y monthly) value of 2.16. The stock’s trailing 12-month PE ratio is 10.80, while the earnings-per-share (ttm) stands at $2.56. The company has a PEG of 0.86 and a Quick Ratio of 0.52 with the debt-to-equity ratio at 0.47. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.95% over the week and 2.35% over the month.
Earnings per share for the fiscal year are expected to decrease by -1.84%, and 0.45% over the next financial year. EPS should shrink at an annualized rate of 12.60% over the next five years, compared to 14.58% over the past 5-year period.
Looking at the support for the MRO, a number of firms have released research notes about the stock. Scotiabank stated their Sector Perform rating for the stock in a research note on July 12, 2024, with the firm’s price target at $45-$29. Barclays coverage for the Marathon Oil Corporation (MRO) stock in a research note released on April 10, 2024 offered a Overweight rating with a price target of $35. Argus was of a view on March 14, 2024 that the stock is Buy, while Morgan Stanley gave the stock Equal-Weight rating on December 11, 2023, issuing a price target of $27- $25. Goldman on their part issued Neutral rating on July 12, 2023.
